Nanjing Hicin Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 377.95 million compared to CNY 379.21 million a year ago. Revenue was CNY 377.95 million compared to CNY 379.21 million a year ago.

Net income was CNY 22.42 million compared to CNY 20.08 million a year ago. Basic earnings per share from continuing operations was CNY 0.1869 compared to CNY 0.1674 a year ago. Diluted earnings per share from continuing operations was CNY 0.1869 compared to CNY 0.1674 a year ago.